Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics

Sonoma Pharmaceuticals, Inc. (SNOA): $0.16

0.00 (1.02%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add SNOA to Watchlist
Sign Up

SNOA Price/Volume Stats

Current price $0.16 52-week high $1.52
Prev. close $0.16 52-week low $0.12
Day low $0.15 Volume 150,397
Day high $0.16 Avg. volume 1,657,472
50-day MA $0.15 Dividend yield N/A
200-day MA $0.45 Market Cap 2.48M

SNOA Stock Price Chart Interactive Chart >


Sonoma Pharmaceuticals, Inc. (SNOA) Company Bio


Sonoma Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. Sonoma Pharmaceuticals serves customers worldwide.


SNOA Latest News Stream


Event/Time News Detail
Loading, please wait...

SNOA Latest Social Stream


Loading social stream, please wait...

View Full SNOA Social Stream

Latest SNOA News From Around the Web

Below are the latest news stories about SONOMA PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SNOA as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!

William White on InvestorPlace | December 5, 2023

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Gross profit percentage of 36% for the quarter, up 1% from first fiscal quarter 2024Total operating expenses decreased for the quarter and six months ended September 30, 2023 compared to same period prior yearEuropean revenues increased 3% for the ...

Yahoo | November 13, 2023

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

BOULDER, CO / ACCESSWIRE / November 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, ...

Yahoo | November 3, 2023

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

BOULDER, CO / ACCESSWIRE / October 26, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, ...

Yahoo | October 26, 2023

Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference

JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu

Yahoo | September 21, 2023

Read More 'SNOA' Stories Here

SNOA Price Returns

1-mo 13.48%
3-mo -3.85%
6-mo -13.98%
1-year -84.31%
3-year -98.01%
5-year -97.98%
YTD -11.31%
2023 -83.89%
2022 -75.44%
2021 -37.19%
2020 66.51%
2019 -31.77%

Continue Researching SNOA

Want to see what other sources are saying about Sonoma Pharmaceuticals Inc's financials and stock price? Try the links below:

Sonoma Pharmaceuticals Inc (SNOA) Stock Price | Nasdaq
Sonoma Pharmaceuticals Inc (SNOA) Stock Quote, History and News - Yahoo Finance
Sonoma Pharmaceuticals Inc (SNOA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!